Eye Drop Imaging Technology, LLC
USPTO PatentsView assignee record - 13 granted patents across 4 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Eye ranks #21,118 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 4 technology areas.
- #21,118
- of 49,997 US assignees by volume
- 4th percentile
- by Innovation Score (17.7/100)
- 2.5
- avg claims per patent
- -92%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R21118 · US Corporation #21,118 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 13 grants
- MID-PACK #21,118/49,997
- PHOTO-FINISH Exedy GlobalParts
- CPC-NARROW A61B · 4 areas
- INNOV-LOW 17.7/100
- CLAIMS-SPARSE 2.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -92% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Exedy GlobalParts Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Eye’s 17.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Eye
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Eye Drop Imaging… · this assignee 18
Eye Drop Imaging… · this assignee
18 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Eye's Innovation Score is 17.7/100 (4th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Eye?
Each dot is one of Eye’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Eye’s own 2.5 claims/patent is at or below the 18.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Eye's grants concentrate
Eye Drop Imaging Technology, LLC is a focused PatentsView assignee: 4 CPC subclasses with 7.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (7 grants) versus a trough of 1 in 2017. By volume, Eye sits between Exedy GlobalParts Corporation and Ferplast S.P.A..
Who files at Eye's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Exedy Globalparts
Exedy GlobalParts Corporation
13 patents
- Exelus
Exelus Inc.
13 patents
- Exoanalytic Solut…
ExoAnalytic Solutions, Inc.
13 patents
- Exponential
Exponential Technologies, Inc.
13 patents
- FAS Medic
FAS Medic S.A.
13 patents
- FBS
FBS, Inc.
13 patents
- Fdna
Fdna, Inc.
13 patents
- Ferplast S P A
Ferplast S.P.A.
13 patents
- Eye Drop Imaging… ◀
Eye Drop Imaging Technology, LLC
13 patents
What this shows Eye holds 13 patents at rank #21,116, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Eye
By rank, the assignees closest to #21,116 in granted patent volume.
- Exedy GlobalParts Corporation #21,112 · 13 patents
- Exelus Inc. #21,113 · 13 patents
- ExoAnalytic Solutions, Inc. #21,114 · 13 patents
- Exponential Technologies, Inc. #21,115 · 13 patents
- FAS Medic S.A. #21,117 · 13 patents
- FBS, Inc. #21,118 · 13 patents
- Fdna, Inc. #21,119 · 13 patents
- Ferplast S.P.A. #21,120 · 13 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Eye's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Eye's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
18 4th percentile higher than 4% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 15.4% |
| 2017 | 1 | 7.7% |
| 2018 | 7 | 53.8% |
| 2019 | 2 | 15.4% |
| 2020 | 1 | 7.7% |
Which technologies does Eye Drop Imaging Technology, LLC patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Eye Drop Imaging Technology, LLC's patent record in context - here's where to go next.
- Eye Drop Imaging Technology, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 7.7% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #21,118 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Eye Drop Imaging Technology, LLC against Exedy GlobalParts Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 17.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.